Delivery Order SPE2DR25D3304-SPE2DR26F48J9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,387.34 for Lidocaine 5% patches (30-count units) by the Defense Logistics Agency on December 31, 2025. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 2, 2026. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 7, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $5,336.70. This firm fixed-price delivery order is not set aside and is scheduled for ultimate completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on July 8, 2025. The delivery order, valued at $4,520.16, represents a competitive award with no set-aside designation and an ultimate completion date of July 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $6,016.01. The contract is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and carries no set-aside designation. This award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,361.04 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Lidocaine 5% Patch 30s. The contract employs firm fixed-price pricing with a completion deadline of August 18, 2025, and was awarded through open competition with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,249.51 by the Defense Logistics Agency on January 14, 2026, for the supply of Lidocaine 5% Patch 30s. The contract employs firm fixed-price pricing with an ultimate completion date of January 15, 2026, and was competitively awarded with no set-aside designation. This delivery order operates as a child contract under Cencora, Inc. (Amerisourcebergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency for the supply of Lidocaine 5% Patch 30s. This firm fixed-price, competitively awarded delivery order has a ceiling value of $8,340.90 and an ultimate completion date of September 12, 2025. The contract does not utilize a set-aside designation and will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Lidocaine 5% patches in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,866.10 and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation and was awarded competitively. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48J9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 13, 2026, by the Defense Logistics Agency (DLA) for Lidocaine 5% Patch 30s with a ceiling value of $2,390.40. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and no set-aside designation was applied. This award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Lidocaine 5% Patch delivery represents a routine fulfillment under AmerisourceBergen's prime IDC, which serves as a critical procurement vehicle for pain management pharmaceuticals and other medical commodities across the Defense Health Agency and related federal healthcare systems. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which holds the overarching IDC vehicle. The company's federal contract portfolio demonstrates consistent capability in delivering both specialty medications and generic drugs through competitive, firm fixed-price arrangements, positioning it as a key vendor for military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/12/26 |